Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Complement factor B inhibitors discovered at Shanghai Meiyue Biotech Development

March 2, 2022

Study finds potential entry points to Huntington's therapy

March 1, 2022

Fibulin-2 as a novel therapeutic target in multiple sclerosis

March 1, 2022

Murine model reveals aging to promote autoimmune encephalomyelitis with meningeal inflammation

Feb. 28, 2022

Novel murine model developed to test CNS-penetrant BTK inhibitors

Feb. 28, 2022

Bryostatin-1 promotes regenerative phenotype within microglia and CNS macrophages

Feb. 28, 2022

Targeting HNRNPA1 effective for treating multiple sclerosis-associated neurodegeneration

Feb. 25, 2022

Lung microbiome affects brain immune cells

Feb. 25, 2022

VK-1727 reduces EBV proliferation in cells from patients with multiple sclerosis

Feb. 25, 2022

LABP-66 shows promise for the treatment of multiple sclerosis

Feb. 25, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Capital remains selective in ‘barbell’ biotech market
BioWorld Asia
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...